Latest return on equity
Virax Biolabs Group Return on equity
Virax Biolabs Group (VRAX) return on equity with its verified observation date.
Direct answer
Virax Biolabs Group's return on equity is -78.65%.
The verified market snapshot reports -78.65%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 2, 2026.
Get free Virax Biolabs Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -78.65%
Explore related company data
View Virax Biolabs Group's market capitalizationView Virax Biolabs Group's price-to-book ratioView Virax Biolabs Group's 52-week price rangeView Virax Biolabs Group's revenue growthView Virax Biolabs Group's profit marginView Virax Biolabs Group's debt-to-equity ratioView all Virax Biolabs Group key metricsReturn to Virax Biolabs Group profile